Long non-coding RNA titin-antisense RNA1 contributes to growth and metastasis of cholangiocarcinoma by suppressing microRNA-513a-5p to upregulate stratifin

References

• Bergquist A, Von Seth E. Epidemiology of cholangiocarcinoma. Best Pract Res Clin Gastroenterol. 2015;29(2):221–232.
   PubMed Web of Science ®Google Scholar
• Mazzaferro V, Gorgen A, Roayaie S, et al. Liver resection and transplantation for intrahepatic cholangiocarcinoma. J Hepatol. 2020;72(2):364–377.
   PubMed Web of Science ®Google Scholar
• Doussot A, Jarnagin WR, Azoulay D, et al. Improving actual survival after hepatectomy for intrahepatic cholangiocarcinoma-still a long way to go. Hepatobiliary Surg Nutr. 2019;8(2):161–163.
   PubMed Web of Science ®Google Scholar
• Ren H, Luo, M, Chen, J, et al. Identification of TPD52 and DNAJB1 as two novel bile biomarkers for cholangiocarcinoma by iTRAQ‑based quantitative proteomics analysis. Oncol Rep. 2019;42(6):2622–2634.
   PubMed Web of Science ®Google Scholar
• Ricciuti B, Mencaroni C, Paglialunga L, et al. Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy. Med Oncol. 2016;33(2):18.
   PubMed Web of Science ®Google Scholar
• Hanly DJ, Esteller M, Berdasco M. Interplay between long non-coding RNAs and epigenetic machinery: emerging targets in cancer? Philos Trans R Soc Lond B Biol Sci. 2018; 373(1748): 0074.
   Web of Science ®Google Scholar
• Rafiee A, Riazi-Rad F, Havaskary M, et al. Long noncoding RNAs: regulation, function and cancer. Biotechnol Genet Eng Rev. 2018;34(2):153–180.
   PubMed Web of Science ®Google Scholar
• Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017;36(41):5661–5667.
   PubMed Web of Science ®Google Scholar
• Sanchez Calle A, Kawamura Y. Emerging roles of long non-coding RNA in cancer. Cancer Sci. 2018;109(7):2093–2100.
   PubMed Web of Science ®Google Scholar
• Jiang MC, Ni -J-J, Cui W-Y, et al. Emerging roles of lncRNA in cancer and therapeutic opportunities. Am J Cancer Res. 2019;9(7):1354–1366.
   PubMed Web of Science ®Google Scholar
• Zheng B, Jeong S, Zhu Y, et al. miRNA and lncRNA as biomarkers in cholangiocarcinoma(CCA). Oncotarget. 2017;8(59):100819–100830.
   PubMedGoogle Scholar
• Li J, Huang L, Li Z, et al. Functions and roles of long noncoding RNA in cholangiocarcinoma. J Cell Physiol. 2019;234(10):17113–17126.
   PubMed Web of Science ®Google Scholar
• Lv Y, Wang Z, Zhao K, et al. Role of noncoding RNAs in cholangiocarcinoma (Review). Int J Oncol. 2020;57(1):7–20.
   PubMed Web of Science ®Google Scholar
• Shen L, Wu Y, Li A, et al. LncRNA TTN‑AS1 promotes endometrial cancer by sponging miR‑376a‑3p. Oncol Rep. 2020;44(4):1343–1354.
   PubMed Web of Science ®Google Scholar
• Zheng QX, Wang J, Gu X-Y, et al. TTN-AS1 as a potential diagnostic and prognostic biomarker for multiple cancers. Biomed Pharmacother. 2021;135:111169.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li D, Lu J, et al. Long noncoding RNA TTN-AS1 facilitates tumorigenesis and metastasis by maintaining TTN expression in skin cutaneous melanoma. Cell Death Dis. 2020;11(8):664.
   PubMed Web of Science ®Google Scholar
• Liu X, Li Y, Wen J, et al. Long non-coding RNA TTN-AS1 promotes tumorigenesis of ovarian cancer through modulating the miR-139-5p/ROCK2 axis. Biomed Pharmacother. 2020;125:109882.
   PubMed Web of Science ®Google Scholar
• Li S, Liu F, Pei Y, et al. Long noncoding RNA TTN-AS1 enhances the malignant characteristics of osteosarcoma by acting as a competing endogenous RNA on microRNA-376a thereby upregulating dickkopf-1. Aging (Albany NY). 2019;11(18):7678–7693.
   PubMedGoogle Scholar
• Zhu H, Zhai B, He C, et al. LncRNA TTN-AS1 promotes the progression of cholangiocarcinoma via the miR-320a/neuropilin-1 axis. Cell Death & Disease. 2020;11(8):637.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Chen L, Shi J, Wu Y, et al. CircRNA CDR1as promotes hepatoblastoma proliferation and stemness by acting as a miR-7-5p sponge to upregulate KLF4 expression. Aging (Albany NY). 2020;12(19):19233–19253.
   PubMedGoogle Scholar
• Liu K, Zhao D, Wang D. LINC00528 regulates myocardial infarction by targeting the miR-143-3p/COX-2 axis. Bioengineered. 2020;11(1):11–18.
   PubMed Web of Science ®Google Scholar
• Yin D, Lu X. Silencing of long non-coding RNA HCP5 inhibits proliferation, invasion, migration, and promotes apoptosis via regulation of miR-299-3p/SMAD5 axis in gastric cancer cells. Bioengineered. 2021;12(1):225–239.
   PubMed Web of Science ®Google Scholar
• Pan G, Mao A, Liu J, et al. Circular RNA hsa_circ_0061825 (circ-TFF1) contributes to breast cancer progression through targeting miR-326/TFF1 signalling. Cell Prolif. 2020;53(2):e12720.
   PubMed Web of Science ®Google Scholar
• Liang H, Wang F, Chu D, et al. miR-93 functions as an oncomiR for the downregulation of PDCD4 in gastric carcinoma. Sci Rep. 2016;6(1):23772.
   PubMedGoogle Scholar
• Wang G, Bai X, Jiang G, et al. GIT1 overexpression promotes epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma. Bioengineered. 2021;12(1):30–43.
   PubMed Web of Science ®Google Scholar
• Zhu H, Zhai B, He C, et al. LncRNA TTN-AS1 promotes the progression of cholangiocarcinoma via the miR-320a/neuropilin-1 axis. Cell Death Dis. 2020;11(8):637.
   PubMed Web of Science ®Google Scholar
• Yu J, Zhang B, Zhang H, et al. E2F1-induced upregulation of long non-coding RNA LMCD1-AS1 facilitates cholangiocarcinoma cell progression by regulating miR-345-5p/COL6A3 pathway. Biochem Biophys Res Commun. 2019;512(2):150–155.
   PubMed Web of Science ®Google Scholar
• Mano Y, Aishima S, Fukuhara T, et al. Decreased roundabout 1 expression promotes development of intrahepatic cholangiocarcinoma. Hum Pathol. 2013;44(11):2419–2426.
   PubMed Web of Science ®Google Scholar
• Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77(15):3965–3981.
   PubMed Web of Science ®Google Scholar
• Long J, Xiong J, Bai y, et al. Construction and Investigation of a lncRNA-associated ceRNA regulatory network in cholangiocarcinoma. Front Oncol. 2019;9:649.
   PubMed Web of Science ®Google Scholar
• Salati M, Braconi C. Noncoding RNA in Cholangiocarcinoma. Semin Liver Dis. 2019;39(1):13–25.
   PubMed Web of Science ®Google Scholar
• Qi G, Li L. LncRNA TTN-AS1 promotes progression of non-small cell lung cancer via regulating miR-491-5p/ZNF503 Axis. Onco Targets Ther. 2020;13:6361–6371.
   PubMedGoogle Scholar
• Feng H, Wang Q, Xiao W, et al. LncRNA TTN-AS1 regulates miR-524-5p and RRM2 to promote breast cancer progression. OncoTargets and Therapy. 2020;13:4799–4811.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Yang Z, Luo X-H, et al. Long noncoding RNA TTN-AS1 promotes the proliferation and migration of prostate cancer by inhibiting miR-1271 level. Eur Rev Med Pharmacol Sci. 2019;23(24):10678–10684.
   PubMed Web of Science ®Google Scholar
• Miao S, Wang J, Xuan L, et al. LncRNA TTN-AS1 acts as sponge for miR-15b-5p to regulate FBXW7 expression in ovarian cancer. BioFactors (Oxford, England). 2020;46(4):600–607.
   PubMed Web of Science ®Google Scholar
• Fu D, Lu C, Qu X, et al. LncRNA TTN-AS1 regulates osteosarcoma cell apoptosis and drug resistance via the miR-134-5p/MBTD1 axis. Aging (Albany NY). 2019;11(19):8374–8385.
   PubMedGoogle Scholar
• Wang Y, Jiang F, Xiong Y, et al. LncRNA TTN-AS1 sponges miR-376a-3p to promote colorectal cancer progression via upregulating KLF15. Life Sci. 2020;244:116936.
   PubMed Web of Science ®Google Scholar
• Zhu X, Jiang S, Wu Z, et al. Long non-coding RNA TTN antisense RNA 1 facilitates hepatocellular carcinoma progression via regulating miR-139-5p/SPOCK1 axis. Bioengineered. 2021;12(1):578–588.
   PubMed Web of Science ®Google Scholar
• Li F, Wu X, Zhang Y, et al. Plasma miR-513a-5p as a potential biomarker for diagnosis of nonalcoholic fatty liver disease in type 2 diabetes mellitus patients. Clin Lab. 2020;66(5). DOI:10.7754/Clin.Lab.2019.190907.
   Web of Science ®Google Scholar
• Shin S, Moon KC, Park KU, et al. MicroRNA-513a-5p mediates TNF-α and LPS induced apoptosis via downregulation of X-linked inhibitor of apoptotic protein in endothelial cells. Biochimie. 2012;94(6):1431–1436.
   PubMed Web of Science ®Google Scholar
• Dong X, Xu M, Ren Z, et al. Regulation of CBL and ESR1 expression by microRNA-22‑3p, 513a-5p and 625-5p may impact the pathogenesis of dust mite-induced pediatric asthma. Int J Mol Med. 2016;38(2):446–456.
   PubMed Web of Science ®Google Scholar
• Fan K, Ruan X, Wang L, et al. Circ_0004872 promotes platelet-derived growth factor-BB-induced proliferation, migration and dedifferentiation in HA-VSMCs via miR-513a-5p/TXNIP axis. Vascul Pharmacol. 2021;140:106842.
   PubMed Web of Science ®Google Scholar
• Zhao JL, Zhao LL, Niu WZ, et al. [Deleted in lymphocytic leukemia 1 promoted proliferation and apoptosis of nephroblastoma cells through regulating miR-513a-5p and RANBP2 pathway]. Zhonghua Zhong Liu Za Zhi. 2020;42(10):849–855.
   PubMedGoogle Scholar
• Xia W, Chen C, Zhang MR, et al. LncRNA PCAT6 aggravates the progression of bladder cancer cells by targeting miR-513a-5p. Eur Rev Med Pharmacol Sci. 2020;24(19):9908–9914.
   PubMed Web of Science ®Google Scholar
• Chen KC, Chen P-H, Ho K-H, et al. IGF-1-enhanced miR-513a-5p signaling desensitizes glioma cells to temozolomide by targeting the NEDD4L-inhibited Wnt/β-catenin pathway. PLoS One. 2019;14(12):e0225913.
   PubMed Web of Science ®Google Scholar
• Lu MD, Liu D, Li YX. LINC01436 promotes the progression of gastric cancer via regulating miR-513a-5p/APE1 Axis. Onco Targets Ther. 2020;13:10607–10619.
   PubMed Web of Science ®Google Scholar
• Shi J, Yang Y, Cheng A, et al. Metabolism of vascular smooth muscle cells in vascular diseases. Am J Physiol Heart Circ Physiol. 2020;319(3):H613–h631.
   PubMed Web of Science ®Google Scholar
• Dai N, Qing Y, Cun Y, et al. miR-513a-5p regulates radiosensitivity of osteosarcoma by targeting human apurinic/apyrimidinic endonuclease. Oncotarget. 2018;9(39):25414–25426.
   PubMedGoogle Scholar
• Li C, Yu Z, Ye J. MicroRNA-513a-3p regulates colorectal cancer cell metabolism via targeting hexokinase 2. Exp Ther Med. 2020;20(1):572–580.
   PubMed Web of Science ®Google Scholar
• Hu Y, Zeng Q, Li C, et al. Expression profile and prognostic value of SFN in human ovarian cancer Biosci Rep. 2019;39(5):BSR20190100.
   PubMedGoogle Scholar
• Sirivatanauksorn V, Dumronggittigule W, Dulnee B, et al. Role of stratifin (14-3-3 sigma) in adenocarcinoma of gallbladder: a novel prognostic biomarker. Surg Oncol. 2020;32:57–62.
   PubMed Web of Science ®Google Scholar
• Hu Y, Ma Y, Liu J, et al. LINC01128 expedites cervical cancer progression by regulating miR-383-5p/SFN axis. BMC Cancer. 2019;19(1):1157.
   PubMed Web of Science ®Google Scholar
• Zhang T, Lei F, Jiang T, et al. H19/miR-675-5p targeting SFN enhances the invasion and metastasis of nasalpharyngeal cancer cells. Curr Mol Pharmacol. 2019;12(4):324–333.
   PubMed Web of Science ®Google Scholar
• Shiba-Ishii A, Hong J, Hirokawa T, et al. Stratifin Inhibits SCFFBW7 formation and blocks ubiquitination of oncoproteins during the course of lung adenocarcinogenesis. Clin Cancer Res. 2019;25(9):2809–2820.
   PubMed Web of Science ®Google Scholar
• Shiba-Ishii A, Kim Y, Shiozawa T, et al. Stratifin accelerates progression of lung adenocarcinoma at an early stage. Mol Cancer. 2015;14(1):142.
   PubMedGoogle Scholar
• Hu Y, Ma Y, Liu J, et al. LINC01128 expedites cervical cancer progression by regulating miR-383-5p/SFN axis. BMC Cancer. 2019;19(1):1157.
   PubMed Web of Science ®Google Scholar